参考文献/References:
［1］ ZHANG S，NG M K.Gene-microRNA network module analysis for ovarian cancer［J］.BMC Syst Biol,2016,10(Suppl 4):117.
［2］ TAUCHER V，MANGGE H，HAYBAECK J.Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application［J］.Cell Oncol (Dordr),2016,39(4):295-318.
［3］ PAOLILLO C，LONDIN E，FORTINA P.Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine［J］.Scand J Clin Lab Invest Suppl,2016,245:S84-S91.
［4］ MIRHANII H，UGOLIN N，ORY C，et al.Comparative analysis of micro-RNAs in human papillomavirus-positive versus -negative oropharyngeal cancers［J］.Head Neck,2016,38(11):1634-1642.
［5］ SUN X，LIN J，ZHANG Y，et al.MicroRNA-181b improves glucose homeostasis and insulin sensitivity by regulating endothelial function in white adipose tissue［J］.Circ Res,2016,118(5):810-821.
［6］ PARASKEVOPOULOU M D，HATZIGEORGIOU A G.Analyzing miRNA-lncRNA interactions［J］.Methods Mol Biol,2016,1402:271-286.
［7］ ZHANG X，LI D，LI M，et al.MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development［J］.Int J Cancer,2014,134(2):257-267.
［8］ CORNETT A L，LUTZ C S.Regulation of COX-2 expression by miR-146a in lung cancer cells［J］.RNA,2014,20(9):1419-1430.
［9］ FEMMINELLA G D，FERRARA N，RENGO G.The emerging role of micrornas in alzheimer′s disease［J］.Front Physiol,2015,6:40-41.
［10］ ZHOU Y X，ZHAO W，MAO L W，et al.Long non-coding RNA NIFK-AS1 inhibits m2 polarization of macrophages in endometrial cancer through targeting miR-146a［J］.Int J Biochem Cell Biol,2018,104:25-33.
［11］ IACONA J R，LUTZ C S.MiR-146a-5p: expression，regulation，and functions in cancer［J］.Wiley Interdiscip Rev RNA,2019,10(4):e1533.
［12］ KULIS M，ESTELLER M.DNA methylation and cancer［J］.Adv Genet,2010,70:27-56.
［13］ ZHANG Z，ZHANG Y，SUN X X，et al.MicroRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma［J］.Mol Cancer,2015,14:5-6.
［14］ GAO J，WANG D，LIU D，et al.Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype［J］.Mol Biol Cell,2015,26(18):3178-3189.
［15］ TAN J Z，YAN Y，WANG X X，et al.EZH2: biology，disease，and structure-based drug discovery［J］.Acta Pharmacol Sin,2014,35(2):161-174.
［16］ WANG C，GUAN S，LIU F，et al.Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma［J］.Br J Cancer,2016,114(3):290-297.
［17］ WANG C，ZHANG W，ZHANG L，et al.MiR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2［J］.Br J Cancer,2018,118(6):e12.
［18］ WU H，LIU Q，CAI T，et al.Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma［J］.Mol Med Rep,2015,12(4):5461-5466.
［19］ KARTHIKEYAN A，GUPTA N，TANG C，et al.Microglial SMAD4 regulated by microRNA-146a promotes migration of microglia which support tumor progression in a glioma environment［J］.Oncotarget,2018,9(38):24950-24969.
［20］ LIU W，HE J，YANG Y，et al.Upregulating miR-146a by physcion reverses multidrug resistance in human chronic myelogenous leukemia K562/ADM cells［J］.Am J Cancer Res,2016,6(11):2547-2560.
［21］ VANG S，WU H T，FISCHER A，et al.Identification of ovarian cancer metastatic miRNAs［J］.PLoS One,2013,8(3):e58226.
［22］ CUI Y，SHE K，TIAN D，et al.MiR-146a inhibits proliferation and enhances chemosensitivity in epithelial ovarian cancer via reduction of SOD2［J］.Oncol Res,2016,23(6):275-282.
［23］ WILCZYNSKI M，ZYTKO E，SZYMANSKA B，et al.Expression of miR-146a in patients with ovarian cancer and its clinical significance［J］.Oncol Lett,2017,14(3):3207-3214.
［24］ XU B，HUANG Y，NIU X，et al.Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1［J］.Prostate,2015,75(16):1896-1903.
［25］ SUN Q，ZHAO X，LIU X，et al.MiR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1［J］.Prostate,2014,74(16):1613-1621.
［26］ LIU H T，FANG L，CHENG Y X，et al.LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a［J］.Cancer Med,2016,5(12):3512-3519.
［27］ WANG X，GAO H，REN L，et al.Demethylation of the miR-146a promoter by 5-Aza-2′-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer［J］.BMC Cancer,2014,14:308.
［28］ LIU R，YI B，WEI S，et al.FOXP3-miR-146-NF-kappaB axis and therapy for precancerous lesions in prostate［J］.Cancer Res,2015,75(8):1714-1724.
［29］ PANIGRAHI G K，RAMTEKE A，BIRKS D，et al.Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer［J］.Oncotarget,2018,9(17):13894-13910.
［30］ WOTSCHOFSKY Z，GUMMLICH L，LIEP J，et al.Integrated microRNA and mRNA signature associated with the transition from the locally confined to the metastasized clear cell renal cell carcinoma exemplified by miR-146-5p［J］.PLoS One,2016,11(2):e0148746.
［31］ GAKIS G.The role of inflammation in bladder cancer［J］.Adv Exp Med Biol,2014,816:183-196.
［32］ ANDREU Z，OTTA OSHIRO R，REDRUELLO A，et al.Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression［J］.Eur J Pharm Sc,2017,98:70-79.
［33］ SASAKI H，YOSHIIKE M，NOZAWA S，et al.Expression level of urinary microRNA-146a-5p is increased in patients with bladder cancer and decreased in those after transurethral rlesection［J］.Clin Genitourin Cancer,2016,14(5):e493-e499.
［34］ MEARINI E，POLI G，COCHETTI G，et al.Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer［J］.Onco Targets Ther,2017,10:2665-2673.
［35］ FORLONI M，DOGRA S K，DONG Y，et al.miR-146a promotes the initiation and progression of melanoma by activating notch signaling［J］.Elife,2014,3:e01460.
［36］ RAIMO M，ORSO F，GRASSI E，et al.MiR-146a exerts differential effects on melanoma growth and metastatization［J］.Mol Cancer Res,2016,14(6):548-562.
［37］ PU W，SHANG Y，SHAO Q，et al.MiR-146a promotes cell migration and invasion in melanoma by directly targeting SMAD4［J］.Oncol Lett,2018,15(5):7111-7117.
［38］ DE VEIRMAN K，WANG J，XU S，et al.Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity［J］.Cancer Lett,2016,377(1):17-24.
［39］ CHENG Q，LI X，LIU J，et al.Multiplemyeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a［J］.Stem Cells Int,2017,2017:9012152.
［40］ SHIGA K，HARA M，NAGASAKI T，et al.Cancer-associated fibroblasts: their characteristics and their roles in tumor growth［J］.Cancers (Basel),2015,7(4):2443-2458.
［41］ LIU Q，WANG W，YANG X,et al.MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer［J］.Oncol Rep,2016,36(1):189-196.
［42］ LIU R，LIU C，CHEN D，et al.FOXP3 controls an miR-146/NF-kappaB negative feedback loop that inhibits apoptosis in breast cancer cells［J］.Cancer Res,2015,75(8):1703-1713.
［43］ KUMARASWAMY E，WEND K L，AUGUSTINE L A，et al.BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function［J］.Oncogene,2015,34(33):4333-4346.
［44］ SANDHU R，REIN J，D′ARCY M，et al.Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status［J］.Carcinogenesis,2014,35(11):2567-2575.
［45］ LU D，YAO Q，ZHAN C，et al.MicroRNA-146a promote cell migration and invasion in human colorectal cancer via carboxypeptidase M/src-FAK pathway［J］.Oncotarget,2017,8(14):22674-22684.
［46］ BLEAU A M，REDRADO M，NISTAL-VILLAN E，et al.miR-146a targets c-met and abolishes colorectal cancer liver metastasis［J］.Cancer Lett,2018,414:257-267.
［47］ ZHONG L，HUOT J，SIMARD M J.p38 activation induces production of miR-146a and miR-31 to repress E-selectin expression and inhibit transendothelial migration of colon cancer cells［J］.Sci Rep,2018,8(1):2334.
相似文献/References:
[1]张 科,姬利萍,王桂兰.绝经后出血345 例临床与病理分析[J].新乡医学院学报,2000,17(05):360.
[2]张全温,冯 云.肿瘤标志物联合检测在恶性肿瘤诊断中的价值[J].新乡医学院学报,2006,23(06):619.
[3]李体平,肖 莉,李 桢,等.125碘粒子近距离治疗恶性肿瘤42 例疗效评估[J].新乡医学院学报,2006,23(05):503.
[4]陈小玲,应江山,袁苏徐,等.C 反应蛋白对晚期恶性肿瘤患者的预测价值[J].新乡医学院学报,2012,29(04):000.
[5]吴聪聪,唐方明,陈冠鹏,等.秋水仙碱治疗心血管疾病研究进展[J].新乡医学院学报,2017,34(7):663.[doi:10.7683/xxyxyxb.2017.07.030]
[6]靳彩玲,高建辉,张 敏,等.肿瘤坏死因子-α基因多态性与恶性肿瘤糖代谢异常的关系[J].新乡医学院学报,2016,33(8):680.[doi:10.7683/xxyxyxb.2016.08.008]
JIN Cai-ling,GAO Jian-hui,ZHANG Min,et al.Correlation between tumor necrosis factor-α single nucleotide polymorphisms and abnormal glucose metabolism in patients with malignant tumor[J].Journal of Xinxiang Medical University,2016,33(12):680.[doi:10.7683/xxyxyxb.2016.08.008]
[7]周 涵,魏 静,李 媛,等.色胺酮抗恶性肿瘤分子机制研究进展[J].新乡医学院学报,2022,39(8):791.[doi:10.7683/xxyxyxb.2022.08.018]
ZHOU Han,WEI Jing,LI Yuan,et al.Research progress on the molecular mechanism of tryptanthrin against malignant tumors[J].Journal of Xinxiang Medical University,2022,39(12):791.[doi:10.7683/xxyxyxb.2022.08.018]
[8]连艳红,晁旭,杨小颀.野黄芩苷抗肿瘤作用机制研究进展[J].新乡医学院学报,2023,40(4):386.[doi:10.7683/xxyxyxb.2023.04.017]
LIAN Yanhong,CHAO Xu,YANG Xiaoqi.Research progress on the anti-tumor mechanism of Scutellarin[J].Journal of Xinxiang Medical University,2023,40(12):386.[doi:10.7683/xxyxyxb.2023.04.017]